title: DNA-reactive protein monoepoxides induce cell death and mutagenesis in mammalian cells.
abstract: Although cytotoxic alkylating agents possessing two electrophilic reactive groups are thought to act by cross-linking cellular biomolecules, their exact mechanisms of action have not been established. In cells, these compounds form a mixture of DNA lesions, including nucleobase monoadducts, interstrand and intrastrand cross-links, and DNA-protein cross-links (DPCs). Interstrand DNA-DNA cross-links block replication and transcription by preventing DNA strand separation, contributing to toxicity and mutagenesis. In contrast, potential contributions of drug-induced DPCs are poorly understood. To gain insight into the biological consequences of DPC formation, we generated DNA-reactive protein reagents and examined their toxicity and mutagenesis in mammalian cells. Recombinant human O(6)-alkylguanine DNA alkyltransferase (AGT) protein or its variants (C145A and K125L) were treated with 1,2,3,4-diepoxybutane to yield proteins containing 2-hydroxy-3,4-epoxybutyl groups on cysteine residues. Gel shift and mass spectrometry experiments confirmed that epoxide-functionalized AGT proteins formed covalent DPC but no other types of nucleobase damage when incubated with duplex DNA. Introduction of purified AGT monoepoxides into mammalian cells via electroporation generated AGT-DNA cross-links and induced cell death and mutations at the hypoxanthine-guanine phosphoribosyltransferase gene. Smaller numbers of DPC lesions and reduced levels of cell death were observed when using protein monoepoxides generated from an AGT variant that fails to accumulate in the cell nucleus (K125L), suggesting that nuclear DNA damage is required for toxicity. Taken together, these results indicate that AGT protein monoepoxides produce cytotoxic and mutagenic DPC lesions within chromosomal DNA. More generally, these data suggest that covalent DPC lesions contribute to the cytotoxic and mutagenic effects of bis-electrophiles.
authors.affiliation: Department of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
authors.forename: Natalia Y
authors.initials: NY
authors.lastname: Tretyakova
authors.forename: Erin D
authors.initials: ED
authors.lastname: Michaelson-Richie
authors.forename: Teshome B
authors.initials: TB
authors.lastname: Gherezghiher
authors.forename: Jamie
authors.initials: J
authors.lastname: Kurtz
authors.forename: Xun
authors.initials: X
authors.lastname: Ming
authors.forename: Susith
authors.initials: S
authors.lastname: Wickramaratne
authors.forename: Melissa
authors.initials: M
authors.lastname: Campion
authors.forename: Sreenivas
authors.initials: S
authors.lastname: Kanugula
authors.forename: Anthony E
authors.initials: AE
authors.lastname: Pegg
authors.forename: Colin
authors.initials: C
authors.lastname: Campbell
mesh_terms: D000478:Alkylation; D000595:Amino Acid Sequence; D016923:Cell Death; D045744:Cell Line, Tumor; D002851:Chromatography, High Pressure Liquid; D004247:DNA / Q000378:metabolism*; D004268:DNA-Binding Proteins / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D004852:Epoxy Compounds / Q000494:pharmacology*; D006801:Humans; D008969:Molecular Sequence Data; D016296:Mutagenesis; D011994:Recombinant Proteins / Q000378:metabolism; D021241:Spectrometry, Mass, Electrospray Ionization
chemical_list: D004268:DNA-Binding Proteins; D004852:Epoxy Compounds; D011994:Recombinant Proteins; D004247:DNA